ValueAct Holdings, L.P.
"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.
13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.
We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 24 quarters, returned +5.3% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 41.7% of quarters (excess t = -0.54, not statistically significant). Its filings tell you what it bought — not what you should buy.
Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)
Top 18 holdings of 18 · 2026 Q1
| Ticker | Value | Weight | QoQ |
|---|---|---|---|
| V | $700M | | ADD |
| AMZN | $601M | | TRIM |
| CRM | $559M | | HOLD |
| BLK | $525M | | TRIM |
| META | $524M | | TRIM |
| RKT | $402M | | TRIM |
| TOST | $342M | | ADD |
| LLYVK | $335M | | HOLD |
| RBLX | $331M | | TRIM |
| KKR | $303M | | NEW |
| MDB | $254M | | TRIM |
| SSD | $240M | | TRIM |
| SPOT | $174M | | NEW |
| LLYVA | $163M | | HOLD |
| LYV | $95M | | TRIM |
| WIX | $94M | | NEW |
| DIS | $39M | | TRIM |
| CBRE | $32M | | HOLD |
QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.
New positions in 2026 Q1
Method & Limitations
Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.